Title
Disease-Modifying Therapies For Adults With Multiple Sclerosis
Authoring Organization
Publication Month/Year
April 1, 2018
Last Updated Month/Year
January 22, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
To review evidence on starting, switching, and stopping disease-modifying therapies (DMTs) for multiple sclerosis (MS) in people with clinically isolated syndrome (CIS), relapsingremitting MS (RRMS), and progressive forms of MS; and to develop recommendations for starting, switching, and stopping DMTs
Inclusion Criteria
Female, Male, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment
Diseases/Conditions (MeSH)
D009103 - Multiple Sclerosis, D020278 - Demyelinating Autoimmune Diseases, CNS
Keywords
multiple sclerosis (MS), multiple sclerosis, neuromyelitis optica, demyelinating autoimmune diseases
Supplemental Methodology Resources
Methodology Supplement, Methodology Supplement, Methodology Supplement, Methodology Supplement, Systematic Review Document